Firstly, AGA to seven out of the 22 investigated glycans significantly differentiated plasma samples from control women and HGSOC patients in the SGA: the two top AGA, anti-SiaTn and anti-6-OSulfo-TF, and CA125 (standard tumor marker commonly used in the clinics) distinguished with comparable power. This evidence concerns the gene TF and neoplasm.